Scientists who spurred development of mRNA COVID-19 vaccines win Nobel medicine prize

Scientists Katalin Kariko and Drew Weissman won the 2023 Nobel Prize in Physiology or Medicine for discoveries they made at the University of Pennsylvania that enabled the development of effective vaccines against COVID-19, the award-giving body said on Monday.

Kariko and Weissman were honoured for "their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19," the body said.

"MRNA vaccines, together with other COVID-19 vaccines, have been administered over 13 billion times. Together they have saved millions of lives, prevented severe COVID-19, reduced the overall disease burden and enabled societies to open up again," said Thomas Perlmann, member of the Nobel Assembly at the Karolinska Institute.

The Nobel Prize was created by wealthy Swedish inventor Alfred Nobel, who in his will dictated that his estate should be used to fund "prizes to those who, during the preceding year, have conferred the greatest benefit to humankind." The first awards were given out in 1901.

Key development in 2005

Kariko was senior vice-president and head of RNA protein replacement at BioNTech until 2022 and has since acted as an adviser to the company. She is also a professor at the University of Szeged in Hungary and adjunct professor at the University of Pennsylvania's Perelman School of Medicine.

Weissman is professor in vaccine research at the Perelman School.

The two have said they met and began chatting in 1998 while waiting for rationed photocopying machine time.

"Maybe you have some more copy machines now," Kariko said at UPenn on Monday. "I bragged about how I can do RNA, and Drew was interested in vaccines, and that is how our collaboration started."

WATCH l Dr. Christopher Labos on how the winners moved mRNA understanding forward:

Nobel winners made strides in preventing mRNA degradation

1 year ago

Duration 1:21

Dr. Christopher Labos, Montreal-based cardiologist, says mRNA development underlying COVID-19 vaccines was years in the making.

Kariko found a way to prevent the immune system from launching an inflammatory reaction against lab-made mRNA, previously seen as a major hurdle against any therapeutic use of mRNA.

Together with Weissman, she showed in 2005 that adjustments to nucleosides, the molecular letters that write the mRNA's genetic code, can keep the mRNA under the immune system's radar.

"We couldn't get people to notice RNA as something interesting," Weissman said on Monday. "Pretty much everybody gave up on it."

Messenger or mRNA, discovered in 1961, is a natural molecule that serves as a recipe for the body's production of proteins.

The technology breaks from established biotech medicines, generated in complex reactors by genetically modified living cells, then isolated and purified. Messenger RNA, by contrast, works like a software that can be injected into the body to instruct human cells to churn out the desired proteins. Prospective uses include drugs against cancer and vaccines against malaria, influenza and rabies.

Pfizer, in partnership with BioNTech, and Modernawere able to develop mRNA vaccines based on the foundational work conducted by Kariko and Weissman, as well as other scientists, enabling a rapid response as a COVID-19 pandemic was declared by the World Health Organization in mid-March 2020.

Since that time, a vocal anti-vaccine movement has emerged. Olle Kmpe of the Karolinska Institute, responding to a reporter question, said the award would probably not sway those most resistant to receiving vaccines, but that, "giving a Nobel Prize for this COVID-19 vaccine may make hesitant people take the vaccine and be sure it's very efficient and safe."

Gunilla Karlsson Hedestam, also from the institute, said scientists must be transparent and communicate clearly to wider audiences. While the clinical trials for COVID-19 vaccines were accelerated, she said, it was important for people to undertstand that the origins of the work enabling the development of mRNA vaccines date back to the 1990s.

Sir Andrew Pollard, an immunology professor at Oxford University who pursued a different technology when co-developing the lesser-used COVID vaccine by AstraZeneca, said it was "absolutely right that the ground-breaking work" done by Kariko and Weissman should be recognized by the Nobel committee.

Peace Prize revealed on Friday

Prizes in physics, chemistry and literature will be announced this week, with the Nobel Peace Prize winner to be revealed on Friday. The economics prize is announced on Oct. 9.

Winners of this year's Nobel Prizes will get an extra 1 million crowns compared to last year, partly because the Swedish crown has lost around 30 per cent of its value against the euro the past decade. The prize money of 11 million Swedish crowns is the equivalent of $1.36 million Cdn.

The Nobel prizes are presented to the laureates on Dec. 10.